For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

tags

All In The News tagged "School of Public Health"

Local Programs Feed Kids Healthy Meals During Summer Months

Natalie Shaak, operations manager in the Center for Hunger Free Communities, was quoted in a July 10 WTXF-TV (FOX-29) story about providing kids with lunch this summer at the space of the EAT Cafe.

New Tool Looks to Curb Extreme Risks Taken by Firefighters

Jennifer Taylor, PhD, an associate professor in the Dornsife School of Public Health, discussed in a July 7 WCAU-TV (NBC-10) segment some health and safety risks firefighters experience on the job, and efforts by her team to measure the safety culture of fire departments.

Three Orgs Are Bringing Accessible Healthcare and Clinical Trials to West Philly Neighborhoods

Drexel's partnership with the Lazarex Cancer Foundation to establish Community IMPACT, a program that will focus on reducing cancer and improving health outcomes in Philadelphia, starting in West Philadelphia was featured in a July 3 Technically Philly story. The program involves the Dornsife School of Public Health, College of Nursing and Health Professions and College of MedicineLoretta Sweet Jemmott, PhD, vice president for Health and Health Equity and professor in the College of Nursing and Health Professions, was quoted the story.

Democrats and Republicans Agree: Evidence-based Research Should Play a Greater Role in Health Policymaking

Research from Jonathan Purtle, DrPH, an assistant professor in the Dornsife School of Public Health, suggests agreement between Democrats and Republicans on at least one issue: the role of scientific evidence in development of health care policy. The findings were featured in a June 21 Philadelphia Inquirer article. 

Opioid Settlements: Why Insys Is the Tip of the Iceberg

Robert I. Field, PhD, JD, a professor in the Dornsife School of Public Health and Kline School of Law, was interviewed in a June 18 Sirius XM Knowledge@Wharton segment about opioid settlements and opioid maker Insys Therapeutics, who last week filed for bankruptcy protection five days after securing a $225 million settlement with the federal government. 

Study Shows Support for Overdose Prevention Site in Philly Neighborhood

Alexis Roth, PhD, an assistant professor in the Dornsife School of Public Health, led a study in the Journal of Urban Health that surveyed the level of support for a proposed overdose prevention site in Kensington. The research was covered on June 6 by U.S. News and World Report, The Philadelphia Inquirer, STAT Morning Rounds and Philly Voice

Drexel Survey Shows Wider Neighborhood Support for Overdose Prevention Site

Alexis Roth, PhD, an assistant professor in the Dornsife School of Public Health, led a study in the Journal of Urban Health that surveyed attitudes surrounding opening a proposed overdose prevention site in Kensington. The research was covered June 5 by WHYY.org.

Pennsylvania's nail salon laws need an update

Tran Huynh, PhD, an assistant professor in the Dornsife School of Public Health, authors a June 5Philadelphia Inquirer op-ed on safety issues associated with nail salon work.

America's Health Future

Shiriki Kumanyika, PhD, a research professor at the Dornsife School of Public Health, participated in a June 4 Washington Post "Post Live" panel on "America's Health Future." Kumanyika offered insights on how climate change and other factors influence health, and discussed the importance of equitable medical care for all.

Pfizer Had Clues Its Blockbuster Drug Could Prevent Alzheimer's. Why Didn't It Tell the World?

Robert I. Field, PhD, JD, a professor in the Dornsife School of Public Health and Kline School of Law, was quoted in a June 4 Washington Post article about a team of Pfizer researchers who found its rheumatoid arthritis therapy drug could also potentially reduce the risk of Alzheimer’s disease. Field explained the procedures a company must go through to receive regulatory approval to use a drug for a completely different disease.

Using ASCO's Clinical Database for Commercial Research Raises Questions, Ethicists Say

Robert I. Field, PhD, JD, a professor in the Dornsife School of Public Health and Kline School of Law, was quoted in a May 31 Medscape article about the ethical issues associated with allowing companies to sell access to patient data after they have been stripped of identifiers, without asking for patients' permission.

Using ASCO's Clinical Database for Commercial Research Raises Questions, Ethicists Say

Robert I. Field, PhD, JD, a professor in the Dornsife School of Public Health and Kline School of Law, was quoted in a May 31 Medscape article about the ethical issues associated with allowing companies to sell access to patient data after they have been stripped of identifiers, without asking for patients' permission.